中国癌症杂志 ›› 2014, Vol. 24 ›› Issue (8): 589-593.doi: 10.3969/j.issn.1007-3969.2014.08.005

• 论著 • 上一篇    下一篇

嗜铬细胞瘤PLAGL1基因表达及甲基化水平与SDHB基因突变相关性研究

杨立新1,张丽娜2,张天彪3   

  1. 1. 沈阳医学院附属中心医院内分泌科,辽宁 沈阳 110024;
    2. 沈阳医学院附属中心医院重症医学科,辽宁 沈阳 110024;
    3. 中国医科大学生物化学与分子生物学教研室,辽宁 沈阳 110001
  • 出版日期:2014-08-30 发布日期:2014-11-07
  • 通信作者: 杨立新 E-mail:sy_yanglx@126.com
  • 基金资助:
    辽宁省自然科学基金项目(No:201202279)

PLAGL1 gene expression and methylation level and correlation with SDHB mutations in benign and malignant pheochromocytoma

YANG Li-xin1, ZHANG Li-na2, ZHANG Tian-biao3   

  1. 1. Department of Endocrinology, Central Hospital Affiliated to Shenyang Medical College, Shenyang Liaoning 110024,China; 2. Department of Intensive Care Unit, Central Hospital Affiliated to Shenyang Medical College,Shenyang Liaoning 110024, China; 3. Department of Biochemistry and Molecular Biology, China Medical University, Shenyang Liaoning 110001, China
  • Published:2014-08-30 Online:2014-11-07
  • Contact: YANG Li-xin E-mail: sy_yanglx@126.com

摘要:

背景与目的:PLAGL1基因是一种新发现的肿瘤抑制基因,具有诱导凋亡和细胞周期阻滞的功能。本研究旨在检测PLAGL1在嗜铬细胞瘤组织基因表达水平及上游调控区甲基化状态,并分析PLAGL1基因表达、甲基化情况与SDHB基因突变的关系,以探讨其在嗜铬细胞瘤诊断及治疗中的意义。方法:采用实时荧光定量聚合酶链反应(quantitative reverse transcription polymerase chain reactionqRT-PCR)技术检测PLAGL1基因在13例正常肾上腺髓质、32例良性嗜铬细胞瘤组织及54例恶性嗜铬细胞瘤组织中的表达;甲基化特异性聚合酶链反应(methylation-specic polymerase chain reactionMSP)技术检测PLAGL1基因上游调控区甲基化水平。SDHB基因扩增后直接测序分析突变情况。结果:PLAGL1基因在恶性肿瘤组织、良性肿瘤组织及正常肾上腺髓质中的相对表达量分别为(0.527±0.201)(1.517±0.662)(1.734±0.756),在恶性肿瘤组织与良性肿瘤组织及正常组织间表达水平差异显著,良性肿瘤组织与正常组织间差异无统计学意义(P>0.05)PLAGL1的低表达与恶性嗜铬细胞瘤组织PLAGL1基因上游调控区甲基化密切相关,在恶性肿瘤组织、良性肿瘤组织及正常肾上腺髓质中甲基化发生率分别为68.5%(37/54)18.8%(6/32)15.4%(2/13)7例恶性肿瘤组织SDHB基因发生突变,在良性肿瘤组织与正常组织中未检测到突变的发生。结论:PLAGL1基因的低表达与嗜铬细胞瘤恶性程度相关,其低表达与上游调控区甲基化有关,与SDHB基因突变情况有待进一步验证。

关键词: 嗜铬细胞瘤, PLAGL1基因, 实时荧光定量聚合酶链反应, 甲基化特异性聚合酶链反应, SDHB基因

Abstract:

Background and purpose: PLAGL1 gene is a newly discovered gene, which could induce tumor cells’ apoptosis and cell cycle arrest. This study aimed to investigate the expression and the promoter methylation level of PLAGL1 gene and its correlation with SDHB gene mutations in pheochromocytoma. Methods: The expressions of PLAGL1 mRNA was detected by real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) method in 13 cases of normal adrenal medulla, 32 cases of benign pheochromocytoma group and 54 cases of malignant pheochromocytoma. We examined the promoter methylation status by methylation-specific polymerase chain reaction (MSP) and SDHB gene mutation by qRT-PCR amplification and direct sequencing. Results: The relative expression volume of PLAGL1 gene in malignant tumor tissue was (0.527±0.201), which was significant lower than those in benign tumor tissue and normal adrenal medulla[(1.517±0.662) and (1.734±0.756)]. There was no remarkable difference between benign tumor tissue and normal tissue for PLAGL1 gene expression and promoter methylation. PLAGL1 gene methylation rate in malignant tumor tissue, benign tumor tissue and normal adrenal medulla were 68.5%, 18.8% and 15.4% respectively. SDHB gene mutation was detected in 7 malignant tumor tissues, while no mutation was found in benign and normal group. Conclusion: Lower expression status of PLAGL1 gene showed significant correlation with promoter methylation which may be associated with SDHB gene mutation.

Key words: Pheochromocytoma, PLAGL1 gene, Quantitative reverse transcription polymerase chain reaction, Methylation-speci?c polymerase chain reaction, SDHB gene